16-30925782-G-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001382779.1(FBXL19):c.28G>T(p.Ala10Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000349 in 1,487,848 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001382779.1 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FBXL19 | NM_001382779.1 | c.28G>T | p.Ala10Ser | missense_variant | 2/11 | ENST00000338343.10 | NP_001369708.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FBXL19 | ENST00000338343.10 | c.28G>T | p.Ala10Ser | missense_variant | 2/11 | 5 | NM_001382779.1 | ENSP00000339712 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000217 AC: 33AN: 152168Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000581 AC: 5AN: 86096Hom.: 0 AF XY: 0.0000418 AC XY: 2AN XY: 47800
GnomAD4 exome AF: 0.0000135 AC: 18AN: 1335564Hom.: 0 Cov.: 30 AF XY: 0.0000107 AC XY: 7AN XY: 656984
GnomAD4 genome AF: 0.000223 AC: 34AN: 152284Hom.: 0 Cov.: 32 AF XY: 0.000134 AC XY: 10AN XY: 74440
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 06, 2022 | The c.88G>T (p.A30S) alteration is located in exon 2 (coding exon 2) of the FBXL19 gene. This alteration results from a G to T substitution at nucleotide position 88, causing the alanine (A) at amino acid position 30 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at